Study #2020-0702
There is no place like home- A Pragmatic Effectiveness Trial of Technology-enhanced Outpatient Symptom Management to Reduce Acute Care Visits due to Chemotherapy-related Adverse Events
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This clinical trial studies if enhanced outpatient symptom management with telemedicine and remote monitoring can help reduce acute care visit due to chemotherapy-related adverse events. Receiving telemedicine and remote monitoring may help patients have better outcomes (such as fewer avoidable emergency room visits and hospitalizations, better quality of life, fewer symptoms, and fewer treatment delays) than patients who receive usual care.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Clinical Stage IV Esophageal Adenocarcinoma AJCC v8;Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8;Clinical Stage IV Gastric Cancer AJCC v8;Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8;Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8;Clinical Stage IVA Gastric Cancer AJCC v8;Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8;Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8;Clinical Stage IVB Gastric Cancer AJCC v8;Metastatic Colon Carcinoma;Metastatic Esophageal Carcinoma;Metastatic Gastric Carcinoma;Metastatic Liver Carcinoma;Metastatic Malignant Digestive System Neoplasm;Metastatic Malignant Small Intestinal Neoplasm;Metastatic Malignant Thoracic Neoplasm;Metastatic Pancreatic Carcinoma;Metastatic Rectal Carcinoma;Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8;Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8;Pathologic Stage IV Gastric Cancer AJCC v8;Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8;Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8;Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8;Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8;Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8;Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8;Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8;Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8;Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8;Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8;Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8;Stage IV Colon Cancer AJCC v8;Stage IV Hepatocellular Carcinoma AJCC v8;Stage IV Pancreatic Cancer AJCC v8;Stage IV Rectal Cancer AJCC v8;Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8;Stage IVA Colon Cancer AJCC v8;Stage IVA Hepatocellular Carcinoma AJCC v8;Stage IVA Rectal Cancer AJCC v8;Stage IVB Colon Cancer AJCC v8;Stage IVB Hepatocellular Carcinoma AJCC v8;Stage IVB Rectal Cancer AJCC v8;Stage IVC Colon Cancer AJCC v8;Stage IVC Rectal Cancer AJCC v8
Study phase:
Not applicable
Physician name:
Ryan Huey
Department:
Plastic Surgery
For general questions about clinical trials:
1-877-934-6089
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.